Skip to main content
. 2017 May 15;56(10):1147–1152. doi: 10.2169/internalmedicine.56.7886

Table 4.

The Stratified Analysis of the Trial Based on DAS28-ESR.

DAS28-ESR 0 2M 4M 6M 8M 10M 12M
Remission(≤2.6) 55.4% 40.0% 33.3% 52.7% 51.6% 48.4% 67.9%
Low (>2.6 but ≤3.2) 8.9% 16.7% 26.7% 29.1% 25.8% 9.7% 10.1%
Moderate (>3.2 but ≤5.1) 28.6% 40.0% 36.7% 18.2% 22.6% 38.7% 22.0%
High (>5.1) 7.1% 3.3% 3.3% 0.0% 0.0% 3.2% 0.0%
Chi-squared test p=0.152 p=0.007 p<0.001 p=0.523 p=0.160 p<0.001